Study: Cholesterol was lowered with an oral PCSK9 inhibitor.

Published Date: 08 Mar 2023

A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...

Read Full News

Latest News

The Hidden Social Health Risk Quietly Harming Your Patients

As awareness on the negative effects of loneliness grows, this overlooked social health factor may be silently worsening outcomes for nearly one third of adults.

Improve Sleep by Rethinking Drugs in Older Patients

Screen more aggressively for sleep apnea, start with behavioral treatments for insomnia, and limit the use of higher-risk sleep medications in older adults.

Electronic Nudges Speed up Heart Valve Care

Automated electronic clinician notification alerts enhance the timely evaluation and treatment of clinically significant aortic stenosis and mitral regurgitation.

SGLT-2 Drugs May Cut Renal Injury Risk in Hospital Setting

Use of SGLT-2 inhibitor therapy at hospital admission is associated with a 32% reduced risk for acute kidney injury in hospitalised patients, a Dutch study finds.

Ancestry May Shape Cardiac Risk in Black Soccer Players

In a large screening study, Black soccer players of West African ancestry had higher rates of serious cardiac conditions than other players, with risk varying substantially by ancestral origin.

HCM Linked to Higher Risk for Out-of-Hospital Cardiac Arrest

Hypertrophic cardiomyopathy is associated with an increased long term risk for out of hospital cardiac arrest, especially if diagnosed later in life or with heart failure.

Todays Updates

T-DXd Reduces Residual Disease in Early Breast Cancer

Neoadjuvant trastuzumab deruxtecan combination therapy reduces the residual cancer burden in high-risk early breast cancer, even if a pathologic complete response is not achieved, shows analysis.

Todays Updates

T-DXd Reduces Residual Disease in Early Breast Cancer

Neoadjuvant trastuzumab deruxtecan combination therapy reduces the residual cancer burden in high-risk early breast cancer, even if a pathologic complete response is not achieved, shows analysis.

Latest News

As awareness on the negative effects of loneliness grows, this overlooked social health factor may be silently worsening outcomes for nearly one third of adults.

Screen more aggressively for sleep apnea, start with behavioral treatments for insomnia, and limit the use of higher-risk sleep medications in older adults.

Automated electronic clinician notification alerts enhance the timely evaluation and treatment of clinically significant aortic stenosis and mitral regurgitation.

Use of SGLT-2 inhibitor therapy at hospital admission is associated with a 32% reduced risk for acute kidney injury in hospitalised patients, a Dutch study finds.

In a large screening study, Black soccer players of West African ancestry had higher rates of serious cardiac conditions than other players, with risk varying substantially by ancestral origin.

Hypertrophic cardiomyopathy is associated with an increased long term risk for out of hospital cardiac arrest, especially if diagnosed later in life or with heart failure.

News All Time

Postpartum Antihypertensive Use Flags Future Heart Risk

Early postpartum antihypertensive treatment may signal long-term cardiovascular risk in women with hypertensive disorders of pregnancy.

Key Drivers of Ventricular Dysfunction After Pacing

Patients receiving right ventricular pacing — particularly those with a history of ischaemic heart disease and a high pacing burden — often develop left ventricular systolic dysfunction.

Cardiac MRI Gains Central Role in Pericarditis Diagnosis

Cardiac MRI now plays a pivotal role in confirming pericarditis and myocarditis while reducing reliance on biopsy.

Respiratory Diseases Become Biggest Killer Among Men With RA

Respiratory diseases overtook cardiovascular disease in a 10-year study of men in the southwest of England.

Frailty, Not Age, Drives Risk With SGLT2, GLP-1 Meds

Higher risk for genital infections with SGLT2 inhibitors were observed in frail patients among older adults.

Trial: Subclinical AF Burden Not Enough to Guide OAC

The burden of subclinical atrial fibrillation didn’t predict stroke or other embolic events or the impact of direct oral anticoagulation in a NOAH-AFNET 6 substudy.

CVD, ICU Stay Tied to Klebsiella Infection Post-Transplant

Klebsiella infections are common among solid organ transplant recipients older than 50; a history of cardiovascular disease and posttransplant ICU stay of 3 or more days may each raise this risk.

Two Global Forces Are Colliding in Europe’s Waiting Rooms

From sickle cell crises to kidney injury, changing patient profiles and rising temperatures are creating new clinical blind spots.

Pancreatitis Recurrence Risk Lower With GLP-1 Continuation

Contrary to regulatory warnings, research shows no link between the continuation of GLP-1s following acute pancreatitis and an increased risk for recurrence.

Med Op-Ed: Trusty Nurses, Hawthorne Effect on BP, and More

Why nurse scientists could play a key role in public health messaging, how to make sense of noisy blood pressure readings, and how much time doctors spend on mandatory training modules.

Heart Failure Hospitalizations Rose in Younger Patients

The rates of hospitalizations for heart failure rise among patients younger than 65 years and decrease in those aged 65 years or older between 2010 and 2022, a new study finds.

PFA Bests Meds as First-Line Treatment for Persistent AF

Treatment success with pulsed field ablation was higher at 1 year than with antiarrhythmic drug therapy for patients with persistent atrial fibrillation.

Scientists Rethink How Much Lifespan Is in Our Control

Research upending long-held estimates of genetic influence on lifespan could relieve the pressure to get all the lifestyle factors right.

Fibrosis May Predict Outcomes in Aortic Stenosis

In asymptomatic patients with severe aortic stenosis, higher midwall fibrosis burden is linked to a higher risk for adverse outcomes.

CKM Syndrome Associated With Major Risk for Cancer

Patients with cardiovascular-kidney-metabolic syndrome, especially those in the advanced stages at baseline, show a significant risk for incident cancer, stressing the need for risk assessment.

Can Radiation Reduce Refractory Ventricular Tachycardia?

Stereotactic arrhythmia radioablation reduces sustained ventricular tachycardia episodes and defibrillator shocks in patients with treatment-refractory disease, without treatment related deaths.

Recommended News For You

In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.

After three years, responses to mounetuzumab in follicular lymphoma are still stable.

Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?

Adipocytes in the bone marrow offer early indicators of the development of multiple myeloma from MGUS.

New Standard of Care in High-Risk Acute Promyelocytic Leukemia?

Frontline Mosunetuzumab Shows High Response Rates in Follicular Lymphoma

DNA origami offers more accurate imaging in the fight against pancreatic cancer

Recommended Articles For You

HSC Failure in Fanconi Anemia: Mechanisms, Models, and Emerging Therapeutic Pathways 

The Precision Revolution: Bispecific Antibodies and Antibody-Drug Conjugates Reshaping the Oncology Landscape 

Leukemia in Focus: Tools, Trials, and Therapy Strategies for Modern Medical Practice 

Harnessing Cuproptosis: A Novel Nanomedicine Strategy for Triple-Negative Breast Cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

From 40 to 74, the US Preventive Services Task Force advises every two years for screening mammography.

2.

FDA approves rivanetin as the first-line treatment for lung cancer.

3.

Compared to previous estimates, a greater number of patients participate in cancer treatment trials.

4.

'Converging' Evidence of Link Between Air Pollution and Breast Cancer

5.

Doxorubicin-Trabectedin Strategy Boosts Survival in Challenging Sarcoma

1.

Unlocking the Power of Neutrophils: Harnessing Their Disease-Fighting Potential

2.

An Overview Of Daunorubicin: What Is It Used For And How Does It Work?

3.

Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment

4.

Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians

5.

Unlocking the Unknown: A Comprehensive Guide to Stage 4 Vulvar Cancer

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II

2.

Understanding the causes of anemia in adults beyond nutritional deficiencies

3.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

4.

What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?

5.

Newer Immunotherapies for Myeloma- A Comprehensive Overview


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot